286 related articles for article (PubMed ID: 33115436)
1. High-sensitivity Troponin T in hemodialysis patients: a randomized placebo-controlled sub-study investigating angiotensin-II-blockade, variation over time and associations with clinical outcome.
Peters CD; Kjaergaard KD; Christensen KL; Bibby BM; Jespersen B; Jensen JD
BMC Nephrol; 2020 Oct; 21(1):452. PubMed ID: 33115436
[TBL] [Abstract][Full Text] [Related]
2. Short and Long-Term Effects of the Angiotensin II Receptor Blocker Irbesartan on Intradialytic Central Hemodynamics: A Randomized Double-Blind Placebo-Controlled One-Year Intervention Trial (the SAFIR Study).
Peters CD; Kjaergaard KD; Jensen JD; Christensen KL; Strandhave C; Tietze IN; Novosel MK; Bibby BM; Jespersen B
PLoS One; 2015; 10(6):e0126882. PubMed ID: 26030651
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of angiotensin II blockade with irbesartan on inflammatory markers in hemodialysis patients: A randomized double blind placebo controlled trial (SAFIR study).
Peters CD; Kjaergaard KD; Nielsen CH; Christensen KL; Bibby BM; Jensen JD; Jespersen B
Hemodial Int; 2017 Jan; 21(1):47-62. PubMed ID: 27346437
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin blockade and progressive loss of kidney function in hemodialysis patients: a randomized controlled trial.
Kjaergaard KD; Peters CD; Jespersen B; Tietze IN; Madsen JK; Pedersen BB; Novosel MK; Laursen KS; Bibby BM; Strandhave C; Jensen JD
Am J Kidney Dis; 2014 Dec; 64(6):892-901. PubMed ID: 25011693
[TBL] [Abstract][Full Text] [Related]
5. Associations of tissue Doppler imaging with NT-proBNP and hs-TnT: a pilot study in end-stage renal disease.
Dubin RF; Beatty AL; Teerlink JR; Schiller NB; Alokozai D; Johansen KL
Echocardiography; 2014 Nov; 31(10):1205-12. PubMed ID: 24828699
[TBL] [Abstract][Full Text] [Related]
6. Evolution of high-sensitivity troponin-T and echocardiography parameters in patients undergoing high efficiency on-line hemodiafiltration versus conventional low-flux hemodialysis.
Ethier I; Auger D; Beaulieu M; Wesolowska E; Lévesque R
PLoS One; 2019; 14(10):e0223957. PubMed ID: 31639150
[TBL] [Abstract][Full Text] [Related]
7. NT-proBNP and troponin T levels differ after haemodialysis with a low versus high flux membrane.
Laveborn E; Lindmark K; Skagerlind M; Stegmayr B
Int J Artif Organs; 2015 Feb; 38(2):69-75. PubMed ID: 25744196
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of High-Sensitivity Versus Conventional Cardiac Troponin T Assays Among Patients With Type 2 Diabetes Mellitus Undergoing Maintenance Hemodialysis.
Keller T; Wanner C; Krane V; Kraus D; Genser B; Scharnagl H; März W; Drechsler C
Am J Kidney Dis; 2018 Jun; 71(6):822-830. PubMed ID: 29310884
[TBL] [Abstract][Full Text] [Related]
9. Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T.
Aimo A; Januzzi JL; Vergaro G; Richards AM; Lam CSP; Latini R; Anand IS; Cohn JN; Ueland T; Gullestad L; Aukrust P; Brunner-La Rocca HP; Bayes-Genis A; Lupón J; de Boer RA; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Gamble GD; Ling LH; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Troughton R; Doughty RN; Passino C; Emdin M
Eur J Heart Fail; 2020 Nov; 22(11):2078-2088. PubMed ID: 31919929
[TBL] [Abstract][Full Text] [Related]
10. Elevation in high-sensitivity troponin T in heart failure and preserved ejection fraction and influence of treatment with the angiotensin receptor neprilysin inhibitor LCZ696.
Jhund PS; Claggett BL; Voors AA; Zile MR; Packer M; Pieske BM; Kraigher-Krainer E; Shah AM; Prescott MF; Shi V; Lefkowitz M; McMurray JJ; Solomon SD;
Circ Heart Fail; 2014 Nov; 7(6):953-9. PubMed ID: 25277997
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes.
Rørth R; Jhund PS; Kristensen SL; Desai AS; Køber L; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
Eur J Heart Fail; 2019 Jan; 21(1):40-49. PubMed ID: 30537261
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II-Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer: A Randomized Clinical Trial.
Boekhout AH; Gietema JA; Milojkovic Kerklaan B; van Werkhoven ED; Altena R; Honkoop A; Los M; Smit WM; Nieboer P; Smorenburg CH; Mandigers CM; van der Wouw AJ; Kessels L; van der Velden AW; Ottevanger PB; Smilde T; de Boer J; van Veldhuisen DJ; Kema IP; de Vries EG; Schellens JH
JAMA Oncol; 2016 Aug; 2(8):1030-7. PubMed ID: 27348762
[TBL] [Abstract][Full Text] [Related]
13. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study.
Daniels LB; Laughlin GA; Clopton P; Maisel AS; Barrett-Connor E
J Am Coll Cardiol; 2008 Aug; 52(6):450-9. PubMed ID: 18672166
[TBL] [Abstract][Full Text] [Related]
14. Renal and cardiovascular effects of irbesartan in dialysis patients--a randomized controlled trial protocol (SAFIR study).
Peters CD; Kjærgaard KD; Jespersen B; Christensen KL; Jensen JD
Dan Med J; 2013 Apr; 60(4):A4602. PubMed ID: 23651713
[TBL] [Abstract][Full Text] [Related]
15. No significant effect of angiotensin II receptor blockade on intermediate cardiovascular end points in hemodialysis patients.
Peters CD; Kjaergaard KD; Jensen JD; Christensen KL; Strandhave C; Tietze IN; Novosel MK; Bibby BM; Jensen LT; Sloth E; Jespersen B
Kidney Int; 2014 Sep; 86(3):625-37. PubMed ID: 24670413
[TBL] [Abstract][Full Text] [Related]
16. Dialysis vintage and cardiovascular injury as factors influencing long-term survival in peritoneal dialysis and hemodialysis.
Hoppe K; Schwermer K; Olewicz-Gawlik A; Klysz P; Kawka A; Baum E; Sikorska D; Ścigacz K; Roszak M; Lindholm B; Pawlaczyk K; Oko A
Adv Clin Exp Med; 2017; 26(2):251-258. PubMed ID: 28791842
[TBL] [Abstract][Full Text] [Related]
17. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
Pareek M
Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of troponin T, troponin I, and CK-MBmass in patients with chronic renal failure.
Peetz D; Schütt S; Sucké B; Faldum A; Wandel E; Hafner G; Lackner KJ
Med Klin (Munich); 2003 Apr; 98(4):188-92. PubMed ID: 12715142
[TBL] [Abstract][Full Text] [Related]
19. Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients.
Hickman PE; McGill DA; Talaulikar G; Hiremagalur B; Bromley J; Rahman A; Koerbin G; Southcott E; Potter JM
Intern Med J; 2009 Dec; 39(12):812-8. PubMed ID: 20233242
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of combining high sensitive troponin T and N-terminal pro B-type natriuretic peptide in chest pain patients with no persistent ST-elevation.
Melki D; Lind S; Agewall S; Jernberg T
Clin Chim Acta; 2012 May; 413(9-10):933-7. PubMed ID: 22366164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
